Doctors who supervise medical weight loss programs are compassionate providers who understand the complex challenges of obesity and the nuances of treating it
Manfredi Rizzo is former Director, Clinical Medical & Regulatory Department, Novo Nordisk Europe East and South and has given lectures, received honoraria and research support, and participated in conferences, advisory boards and clinical trials sponsored by pharmaceutical industry including Amgen, AstraZeneca, Boehringer Ingelheim, Kowa, Eli Lilly, Meda, Mylan, Merck Sharp & Dohme, Novo Nordisk, Novartis, Roche Diagnostics, Sanofi and Servier
Compounded Semaglutide is a pure GLP-1 agonist
Today, the entire journey can be managed from the comfort of your home
10.3390/polym14040712 [DOI] [PMC free article] [PubMed] [Google Scholar] 275.Khan TTS, et al
Label status: In January 2025, the Ozempic label was updated to state that it is not recommended in patients with severe gastroparesis, but does not indicate that the drug itself may cause the condition
